HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.

Abstract
We evaluated the antimicrobial activity of fusidic acid (CEM-102) against 1140 clinical strains of Gram-positive bacteria obtained from patients with bacteraemia or skin and skin-structure infections collected in more than 30 medical centres in the USA and Canada over a 10-year period (1997-2006). Fusidic acid was very active against meticillin-susceptible Staphylococcus aureus (MSSA), meticillin-resistant S. aureus (MRSA) and coagulase-negative staphylococci (CoNS), with MIC(90) values (minimum inhibitory concentration encompassing 90% of isolates tested) at 0.12mug/mL for US strains of MSSA, MRSA and CoNS and 0.25mug/mL for Canadian strains of MSSA and MRSA. A progressive increase in fusidic acid resistance was observed among Canadian strains of S. aureus (12.2% in 2005-2006) and among Canadian strains of CoNS. In contrast, no fusidic acid resistance was detected among US S. aureus strains and only 1.5% among CoNS. Fusidic acid was equally active against community-acquired MRSA and linezolid-resistant staphylococci. Fusidic acid exhibited equal or greater potency against staphylococci compared with vancomycin, daptomycin and linezolid.
AuthorsMichael A Pfaller, Mariana Castanheira, Helio S Sader, Ronald N Jones
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 35 Issue 3 Pg. 282-7 (Mar 2010) ISSN: 1872-7913 [Electronic] Netherlands
PMID20036520 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Chemical References
  • Anti-Bacterial Agents
  • Fusidic Acid
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Bacteremia (microbiology)
  • Canada
  • Community-Acquired Infections (microbiology)
  • Cross Infection (microbiology)
  • Fusidic Acid (pharmacology)
  • Humans
  • Microbial Sensitivity Tests
  • Soft Tissue Infections (microbiology)
  • Staphylococcal Infections (microbiology)
  • Staphylococcal Skin Infections (microbiology)
  • Staphylococcus (drug effects, isolation & purification)
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: